1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Phobic Disorders in 1 studies
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.
Phobic Disorders: Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krupina, NA | 1 |
| Orlova, IN | 1 |
| Khlebnikova, NN | 1 |
| Grafova, VN | 1 |
| Smirnova, VS | 1 |
| Kukushkin, ML | 1 |
| Kryzhanovskii, GN | 1 |
| Pankova, NB | 1 |
| Rodina, VI | 1 |
1 other study available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Phobic Disorders
| Article | Year |
|---|---|
Experimental depressive-pain syndrome in rats with initial various anxiety-phobic levels: a behavioral study.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anxiety; Denervation; Depressive Disorder; Do | 2002 |